$VERA

$28.30 +$0.31 (1.11%) Close

$VERA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$VERA Management Team

Mr. David Johnson

Chief Operating Officer

Age 56

Compensation -

Sex Male

Dr. Michael Morrissey

Independent Chairman of the Board

Age 64

Compensation $471.6K USD

Sex Male

Dr. Marshall Fordyce

President

Chief Executive Officer

Founder

Director

Age 51

Compensation $5.648M USD

Sex Male

Mr. Sean Grant

Chief Financial Officer

Age 40

Compensation $1.762M USD

Sex Male

Dr. Robert Brenner

Chief Medical Officer

Age 57

Compensation $4.456M USD

Sex Male

Mr. William Turner

Chief Development Officer

Age 59

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. David Johnson Chief Operating Officer	56	-	Male
Dr. Michael Morrissey Independent Chairman of the Board	64	$471.6K USD	Male
Dr. Marshall Fordyce President Chief Executive Officer Founder Director	51	$5.648M USD	Male
Mr. Sean Grant Chief Financial Officer	40	$1.762M USD	Male
Dr. Robert Brenner Chief Medical Officer	57	$4.456M USD	Male
Mr. William Turner Chief Development Officer	59	-	Male

Board of Directors

From the proxy statement filed Apr 9, 2026

Directors

serving now

Independent

10 of 10

stated in the proxy; 1 not stated

Average tenure

5.4 years

from year joined

CEO also chairs the board

Michael M. Morrissey, Ph.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Michael M. Morrissey, Ph.D. Board chair	65	2022 4 years	Independent	None stated	None stated	$386,660
Patrick G. Enright	64	2020 6 years	Independent	None stated	Jazz Pharmaceuticals PLC	$351,660
James R. Meyers	61	2025 1 year	Independent	Audit Committee	Sangamo Therapeutics, Inc., CytomX Therapeutics, Inc.	$740,641
Maha Katabi, Ph.D. Leaving at the meeting	52	2020 6 years	Independent	Nominating and Corporate Governance Committee · Chair	None stated	$346,660
Andrew Cheng, M.D., Ph.D.	59	2017 9 years	Independent	None stated	None stated	$344,160
Christopher Hite	59	2026 0 years	Independent	None stated	None stated	Not stated
Scott Morrison	68	2020 6 years	Independent	None stated	Corvus Pharmaceuticals Inc.	$356,660
Christy Oliger	56	2024 2 years	Independent	None stated	Karyopharm Therapeutics Inc.	$341,660
Marshall Fordyce, M.D. CEO	52	2016 10 years	Not stated	None stated	None stated	Paid as CEO
Kimball Hall	60	2021 5 years	Independent	None stated	None stated	$344,160
Beth Seidenberg, M.D.	69	2016 10 years	Independent	None stated	Sagimet Biosciences	$346,660

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 9, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$VERA Management Team

Mr. David Johnson

Dr. Michael Morrissey

Dr. Marshall Fordyce

Mr. Sean Grant

Dr. Robert Brenner

Mr. William Turner

Board of Directors

Related-party transactions

No related-party transactions disclosed